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Abstract: RT-qPCR is commonly employed in gene expression studies in ectopic 
pregnancy. Most use RN18S1, β-actin or GAPDH as internal controls without validation of 
their suitability as reference genes. A systematic study of the suitability of endogenous 
reference genes for gene expression studies in ectopic pregnancy is lacking. The aims of 
this study were therefore to evaluate the stability of 12 reference genes and suggest those 
that are stable for use as internal control genes in fallopian tubes and endometrium from 
ectopic pregnancy and healthy non-pregnant controls. Analysis of the results showed that 
the genes consistently ranked in the top six by geNorm and NormFinder algorithms, were 
UBC, GAPDH, CYC1 and EIF4A2 (fallopian tubes) and UBC and ATP5B (endometrium). 
mRNA expression of NAPE-PLD as a test gene of interest varied between the groups 
depending on which of the 12 reference genes was used as internal controls. This study 
demonstrates that arbitrary selection of reference genes for normalisation in RT-qPCR 
studies in ectopic pregnancy without validation, risk producing inaccurate data and should 
therefore be discouraged. 
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1. Introduction  
Ectopic pregnancy is a common early pregnancy complication in which the embryo implants 
outside the uterus. It is estimated to complicate 2% of pregnancies and, more importantly, is still 
associated with significant morbidity and mortality in many parts of the world [1,2]. The most 
common site is the fallopian tube (98.3%) with sites such as the ovary, cervix and abdomen only being 
rarely affected [3]. Sadly, the mechanisms that underlie tubal implantation are still not fully understood 
despite the expansion in ectopic pregnancy related research over the last decade [4]. Over the years, 
various tools have been employed to elucidate these mechanisms with one such tool being quantitative 
real time PCR (RT-qPCR). 
RT-qPCR is an important and common technique used to examine changes in gene expression 
levels in various pathological states. It offers an advantage over other methods such as northern 
blotting because of its high sensitivity, specificity, ease of use and broad dynamic range [5,6]. This 
feature albeit advantageous comes with a price i.e., that it is susceptible to variation in extraction and 
experimental processes including differences in RNA extraction, presence of contaminating DNA, 
efficiency of cDNA synthesis etc. [7–9]. These inherent vulnerabilities make normalisation of  
RT-qPCR data an absolute requirement in the interpretation of experimental data. One of the most 
common methods of normalisation is the use of a reference gene whose expression should remain 
constant under various experimental and disease conditions [10]. This compensates for variation in the 
experimental conditions since both the gene of interest and the reference gene are exposed to the same 
experimental conditions. However, in practice, it is unlikely that a perfect reference gene exists since 
several studies have demonstrated that reference genes themselves can be influenced by drugs, 
chemicals and disease states [9]. Therefore, the validity of gene expression results generated by this 
method of normalisation is highly dependent on the optimal selection of endogenous reference genes 
to which the genes of interest are to be normalised. 
In gene expression studies on ectopic pregnancy, the most commonly used reference genes are  
β-actin (ACTB), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and RNA 18S ribosomal 1 
(RN18S1). These genes are often selected arbitrarily without assessing their stability and suitability for 
use as reference genes despite the recommendations from the MIQE (Minimum Information for 
publication of Quantitative real time PCR Experiments) guidelines that justification of the choice and 
number of reference genes should be an essential part of RT-qPCR experiments [11]. This widespread 
practice risks producing inaccurate experimental data and should be discouraged. A study of the 
suitability of endogenous reference genes for relative gene expression studies in fallopian tubes and 
endometrium from ectopic pregnancy is lacking. The aims of this study were therefore to evaluate the 
suitability of 12 commonly used reference genes and to determine which of them are suitable genes for 
normalization of quantification of mRNA expression in fallopian tubes and endometrium from women 
with ectopic pregnancy as well as in non-pregnant women. The candidate genes evaluated were those 
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from the human geNormTM reference gene kit (PrimerDesign, Southampton, UK) i.e., ACTB, ATP 
synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B), Beta-2-microglobulin 
(B2M), Cytochrome c-1 (CYC1), Eukaryotic translation initiation factor 4A isoform 2 (EIF4A2), 
GAPDH, Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide 
(YWHAZ), Ubiquitin C (UBC), Ribosomal protein L13a (RPLA13), Succinate dehydrogenase complex 
subunit A flavoprotein (SDHA), Topoisomerase (DNA) 1 (TOP1), and RN18S1. We also evaluated 
the effects of using each of these genes on the expression of a test gene of interest in order to demonstrate 
the effects (if any) that arbitrary selection of reference genes may have on data interpretation.  
For this aspect of the study, the gene expression of N-acylphosphatidyl-ethanolamide phospholipase D 
(NAPE-PLD) in human endometrium was used. The choice of NAPE-PLD is partly due to our group’s 
interest in evaluating the role of the endocannabinoid system in early mammalian reproduction including 
tubal transport of embryos. For further details on NAPE-PLD and the endocannabinoid system and 
their role in tubal transport and early pregnancy, see reviews by Taylor et al. [12], Bambang et al. [13] 
and Gebeh et al. [4]. 
2. Results and Discussion 
2.1. Patient Characteristics 
There was no significant difference in age (yrs) in both the follicular (n = 4) and luteal (n = 4) phase 
control groups. However, as expected, the age of the non-pregnant group was significantly higher than 
that of the ectopic group (n = 4). The mean ± SD was 43.00 ± 6.27, (follicular), 41.25 ± 4.43 (luteal) 
and 28.75 ± 2.87 (ectopic pregnancy), p = 0.004 (one way ANOVA). There was no significant 
difference in BMI (kg/m2) between the three groups studied. The mean ± SD were as follows:  
27.00 ± 4.97 (follicular), 29.38 ± 9.86 (luteal) and 27.50 ± 4.40 (ectopic pregnancy), p = 0.877 (one 
way ANOVA). 
2.2. General Expression Levels of Endogenous Reference Genes 
Overall, comparison of the Cq values demonstrated a wide variation within and between the groups 
especially the fallopian tube samples as shown in Figure 1. For fallopian tube samples, variation within 
the group was wider in ectopic pregnancy compared to those in the follicular and luteal phases, while 
for endometrial samples (Figure 2) within group variation was comparable in all the three study groups. 
There was a wide range in Cq values from an overall mean ± SEM (n = 12) of 9.61 ± 0.51 (RN18S1) 
to 25.6 ± 1.49 (YWHAZ) in fallopian tubes. This was also similar in the endometrial samples with an 
overall mean ± SEM (n = 12) of 7.94 ± 0.16 (RN18S1) to 22.55 ± 0.11 (SDHA). 
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Figure 1. Expression levels of the 12 reference genes evaluated as shown by their Cq 
values in 12 fallopian tube samples. Samples were from the follicular (Fol, n = 4),  
luteal (Lut, n = 4) phase and ectopic pregnancy (Ect, n = 4). Cq values were obtained from 
the data output file of ABI PRISM 7000 and are inversely proportional to amount of 
mRNA template material present. 
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Figure 2. Expression levels of the 12 reference genes evaluated as shown by their Cq 
values in 12 endometrial samples. Samples were from the follicular (Fol, n = 4),  
luteal (Lut, n = 4) phase and ectopic pregnancy (Ect, n = 4). Cq values were obtained from 
the data output file of ABI PRISM 7000 and are inversely proportional to amount of 
mRNA template material present. 
  
2.3. Analysis of Reference Gene Stability in Fallopian Tubes 
2.3.1. geNorm Algorithm 
In order to select the most suitable gene for normalisation, geNorm ranks the reference genes based 
on their expression stability value (M) with the highest M value equating to the least stable and vice versa. 
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The cut-off for an acceptable reference gene is one with an M value of less than 1.5. The ranking of the 
reference genes evaluated starting from the most stable (lowest M value) to the least stable (highest M 
value) for these experiments were as follows: EIF4A2/CYC1 > UBC > RN18S1 > B2M > GAPDH > 
TOP1 > ATP5B > ACTB > SDHA > YWHAZ > RPL13A (Table 1). The M value for YWHAZ and 
RPL13A were greater than 1.5 indicating that they are unsuitable for use as internal control genes in 
fallopian tubes. 
Table 1. Ranking of reference genes in fallopian tubes using the geNorm (M value) and 
NormFinder (stability value) algorithms. Lower M or stability value indicates more stable 
expression and vice versa. Genes highlighted in bold were those ranking consistently in the 
top half of the table using both algorithms. 
Gene Name Genbank Number 
geNorm 
Ranking 
M Value 
NormFinder 
Ranking 
Stability 
Value 
EIF4A2 NM_001967.3 1 0.41 6 0.119 
CYC1 NM_001916.3 1 0.41 4 0.109 
UBC NM_021009.5 3 0.55 1 0.098 
RN18S1 NR_003286.2 4 0.59 8 0.137 
B2M NM_004048.2 5 0.65 9 0.139 
GAPDH NM_002046.3 6 0.70 5 0.115 
TOP1 NM_003286.2 7 0.94 2 0.100 
ATP5B NM_001686.3 8 1.10 7 0.122 
ACTB NM_001101.3 9 1.28 12 0.154 
SDHA NM_004168.2 10 1.48 11 0.152 
YWHAZ NM_001135699.1 11 1.78 10 0.142 
RPL13A NM_012423.2 12 1.98 3 0.103 
Best combination 
of genes 
 
UBC, CYC1 
& EIF4A2 
- UBC & TOP1 0.064 
geNorm also calculates the pairwise variation between two normalisation factors (NFn and NFn+1 
genes) which gives an indication of the optimal number of reference genes to be used for appropriate 
normalisation of RT-qPCR data. A pairwise variation value of ≤0.15 is the acceptable cut-off below 
which the addition of an extra reference gene does not confer any advantage over the existing genes. 
Although EIF4A2 and CYC1 were the two best genes, their pairwise variation value was greater than 
0.15 (V2/3 = 0.194) indicating that additional genes are required for adequate normalisation. Based on 
analysis by geNorm, EIF4A2, CYC1 and UBC (V3/4 = 0.135) was considered the minimum 
combination suitable for normalisation though theoretically, the best results would be obtained using a 
combination of 6 genes (V5/6 = 0.116) (Figure 3). 
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Figure 3. Determination of the optimal number of reference genes for normalization in 
fallopian tubes (n = 12) based on their (A) pairwise variation (V) analysis using the 
geNorm algorithm and (B) accumulated standard deviation (Acc. SD) using the 
NormFinder algorithm. 
 
(A) 
 
(B) 
2.3.2. NormFinder Algorithm 
NormFinder uses a different mathematical model to geNorm and takes into account the intragroup 
and intergroup variation. In addition, NormFinder calculates a stability value for each reference gene. 
The most stable reference genes are those with the least inter- and intragroup variation and have the 
lowest stability value. The samples were divided into follicular (n = 4) and luteal phase (n = 4) and 
ectopic pregnancy (n = 4) for appropriate analysis by NormFinder. The ranking of the reference genes 
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were as follows (starting from the most stable to the least stable): UBC > TOP1 > RPL13A > CYC1 > 
GAPDH > EIF4A2 > ATP5B > RN18S1 > B2M > YWHAZ > SDHA > ACTB (Table 1). The most 
suitable combination of genes was UBC and TOP1 (combined stability value = 0.064) which was 
different to that obtained using geNorm. Manual inspection of the data suggests that SDHA and 
YWHAZ had a wide intragroup variation while SDHA, YWHAZ and RPL13A had wide intergroup 
variation making them less suitable as reference genes. 
The accumulated standard deviation (Acc. SD) was calculated using NormFinder and is an indicator 
of the optimal number of reference genes to be used for data normalisation. The lowest Acc. SD 
(theoretically indicating the optimal number of reference genes) was obtained when 10 genes were 
used (Acc. SD = 0.052) (Figure 3). However, TOP1 and UBC were selected by NormFinder as the best 
pair of genes for normalisation in fallopian tubes (Table 1). 
2.4. Analysis of Reference Gene Stability in Endometrium 
2.4.1. geNorm Analysis 
The ranking of the reference genes in the endometrium was different to that of the fallopian tubes 
and were as follows (starting from the most stable to the least stable): YWHAZ/UBC > ATP5B > 
SDHA > RN18S1 > EIF4A2 > TOP1 > CYC1 > ACTB > GAPDH > RPL13A > B2M (Table 2). 
Unlike the fallopian tubes, the M value for each of the 12 genes was less than 1.5 indicating that they 
were all reasonably stable enough to be used as reference genes in the endometrium. 
Table 2. Ranking of reference genes in endometrium using the geNorm (M value) and 
NormFinder (stability value) algorithms. Lower M or stability value indicates more stable 
expression and vice versa. Genes highlighted in bold were those ranking consistently in the 
top half of the table using both algorithms. 
Gene Name Genbank Number 
geNorm 
Ranking 
M Value
Normfinder 
Ranking 
Stability 
Value 
YWHAZ NM_001135699.1 1 0.20 8 0.121 
UBC NM_021009.5 1 0.20 3 0.088 
ATP5B NM_001686.3 3 0.30 2 0.081 
SDHA NM_004168.2 4 0.39 7 0.113 
RN18S1 NR_003286.2 5 0.42 10 0.144 
EIF4A2 NM_001967.3 6 0.44 11 0.148 
TOP1 NM_003286.2 7 0.46 5 0.106 
CYC1 NM_001916.3 8 0.47 1 0.074 
ACTB NM_001101.3 9 0.48 9 0.125 
GAPDH NM_002046.3 10 0.49 6 0.106 
RPL13A NM_012423.2 11 0.52 12 0.148 
B2M NM_004048.2 12 0.56 4 0.100 
Best combination 
of genes 
 
UBC & 
YWHAZ 
- UBC & ATP5B 0.056 
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Pairwise variation calculated by geNorm indicated that the combination of the top two reference 
genes in the endometrium i.e., UBC and YWHAZ were stable enough to be used for normalisation 
without the addition of a 3rd gene (V2/3 = 0.112) (Figure 4). Although this was acceptable (V ≤ 0.15), the 
lowest pairwise variation score was obtained with a combination of 10 candidate genes (V9/10 = 0.042). 
Figure 4. Determination of the optimal number of reference genes for normalisation in  
the endometrium (n = 12) based on their (A) pairwise variation (V) analysis using the  
geNorm algorithm and (B) accumulated standard deviation (Acc. SD) using the 
NormFinder algorithm.  
 
(A) 
 
(B) 
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2.4.2. NormFinder Algorithm  
The ranking of the reference genes based on their stability values were as follows (starting from the 
most stable to the least stable): CYC1 > ATP5B > UBC> B2M > TOP1 > GAPDH > SDHA > 
YWHAZ > ACTB > RN18S1 > EIF4A2 > RPL13A (Table 2). 
The lowest Acc. SD (0.041) was obtained using a combination of 10 reference candidates for 
normalisation (Figure 4). However, the most suitable combination of genes recommended by 
NormFinder was UBC and ATP5B (combined stability value = 0.056) which as with the fallopian 
tubes, was different to that obtained using geNorm (Table 2). 
2.5. The Effect of Choice of Using Different Reference Genes to Normalise Data for Genes of Interest 
In order to test the effects of using various reference genes on the gene expression profiles, the 
relative expression of NAPE-PLD mRNA in the endometrium was calculated using each of the  
12 reference genes as internal controls as well as using the recommended combinations of genes from 
both geNorm and NormFinder. The results of our analysis indicated that depending on the reference 
gene selected, NAPE-PLD mRNA appeared either unchanged in all three study groups (e.g., GAPDH, 
TOP1), attenuated in the luteal phase and ectopic pregnancy compared to the follicular phase  
(e.g., UBC, YWHAZ) or that expression may be increased in the luteal phase compared to the 
follicular phase or ectopic pregnancy (e.g., RPL13A) (Figure 5). Interestingly, there was a statistically 
significant increase in NAPE-PLD mRNA expression in the follicular phase compared to the ectopic 
pregnancy group (p < 0.05; one-way ANOVA) using CYC1 as the internal control. This significance 
was not observed when using each of the other genes as internal control (Figure 5). 
Figure 5. NAPE-PLD expression in human endometrium using each of the 12 candidate 
reference genes as internal control. Samples were from the follicular (Fol, n = 4), luteal 
(Lut, n = 4) phase and ectopic pregnancy (Ect, n = 4). Relative NAPE-PLD expression was 
significantly higher (p < 0.05) in the follicular phase than in ectopic pregnancy using 
CYC1 as reference gene. This statistically significant result was not demonstrated when 
using each of the other 11 genes as internal control though there was a tendency towards 
higher levels in the follicular phase than in ectopic pregnancy with most of them. 
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Figure 5. Cont. 
 
 
 
2.6. General Discussion of Results  
To the best of our knowledge, this is the first study that has evaluated the most commonly used 
reference genes for normalisation of RT-qPCR data in ectopic pregnancy. The absence of such a study 
may be due to multiple factors including the possibility that researchers may have relied on extrapolating 
data from similar studies in other tissues or may be selecting internal control genes without thorough 
validation. Many studies have shown the variation in stability of reference gene in various tissues [14,15] 
and we have also shown here that a reference gene which may be deemed more suitable in one tissue 
type may not be suitable in another tissue type even within the same cohort of patients. Justification of 
the choice and number of reference genes should therefore be an essential part of RT-qPCR experiments 
in ectopic pregnancy as recommended by the MIQE guidelines [11]. 
Unlike the endometrial samples, there was a wider variation in Cq values of fallopian tubes from 
both the ectopic pregnancy and the follicular phase compared to luteal phase, which may suggest that 
the local changes occurring in ectopic pregnancy may also modulate the expression of some reference 
genes. Arbitrary selection of reference genes is therefore not an ideal practice as the chosen reference 
genes may be significantly regulated in ectopic pregnancy and risk producing inaccurate data.  
Clearly, there was some variation in the ranking of the individual reference genes using geNorm and 
NormFinder. This is likely due to the different mathematical models used by both algorithms and 
similar findings have been reported in other studies [14,16]. Despite the differences in the ranking of 
the genes in fallopian tubes, the genes that were ranked in the top six by both algorithms were UBC, 
Int. J. Mol. Sci. 2012, 13             
 
 
2821
CYC1, GAPDH and EIF4A2 indicating that these genes are likely to be the most stable for normalisation 
in ectopic pregnancy studies. However, it is unlikely that a single reference gene would be an ideal 
internal control and the use of multiple reference genes is therefore recommended to minimise bias 
resulting from differential expression of one reference gene. On the contrary, a combination of genes is 
likely to produce more accurate results since the overall variation will be minimised. Similarly, both 
algorithms produced consistent results with the genes ranked among the lower half of the table i.e., 
ACTB, SDHA, ATP5B and YWHAZ (Table 1). These genes are therefore likely to be the least 
suitable for use as reference genes. With regards to the endometrium, UBC and ATP5B were the only 
genes ranked within the top six by both algorithms suggesting that they were the most stable genes for 
normalisation in ectopic pregnancy studies utilising healthy non-pregnant women as control groups 
(Table 2). Despite the individual rankings from the endometrial samples, all the 12 genes evaluated 
had M values less than 1.5 (geNorm) indicating good stability.  
In order to demonstrate the effects of using various reference genes on the gene expression profiles, 
the expression of NAPE-PLD mRNA in 12 endometrial samples was calculated using each of the  
12 reference genes as internal control. NAPE-PLD was selected because of our group’s interest in the 
regulation of mammalian reproduction by the endocannabinoid system. Moreover, in a comprehensive 
study by Taylor et al, the mean immunohistochemical score for NAPE-PLD was higher in the mid 
proliferative compared to the mid secretory phase in both the endometrial glands and stroma  [17]. The 
results of our analysis indicated that depending on the reference gene selected, NAPE-PLD mRNA 
appeared either unchanged in all 3 study groups (e.g., GAPDH, TOP1), attenuated in the luteal phase 
and ectopic pregnancy compared to the follicular phase (e.g., UBC, YWHAZ) or that expression may 
be increased in the luteal phase compared to the follicular phase or ectopic pregnancy (e.g., RPL13A) 
(Figure 5). Although the sample size was small, there was nonetheless a significant increase in relative 
NAPE-PLD mRNA expression in the follicular phase compared to ectopic pregnancy using CYC1 as 
the internal control. This statistically significant result was not obtained when each of the other  
11 genes were used for normalisation despite a tendency towards higher levels in the follicular phase 
compared to the two other groups with many of the genes used (Figure 5). NAPE-PLD mRNA 
expression normalised to the most suitable genes as recommended by geNorm or NormFinder 
produced similar results with levels being higher in the follicular than in the luteal phase samples; a 
finding consistent with previous immunohistochemical studies (data not shown)  [17]. One limitation 
of our study and in ectopic pregnancy research in general is the use of non-pregnant luteal phase 
samples as controls. However, obtaining fallopian tubes from normal pregnant women is unethical and 
rare in contemporary practice and coupled with the absence of a validated ex vivo primary human 
fallopian tube epithelium culture system that faithfully recapitulate in vivo epithelium and function, the 
use of these samples for ectopic pregnancy research on human subjects is likely to remain common 
practice. Moreover, the fact that it is in this phase of the cycle that the initial stages of embryo 
development, tubal transport and implantation occur make it a reasonable trade-off between what is 
“ideal” and what is “practical/ethical” while accepting the limitations. Despite these limitations, the 
results clearly demonstrate that a combination of reference genes as recommended by gene stability 
algorithms such as geNorm or NormFinder minimises bias that may result from variation in the 
reference gene itself.  
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3. Experimental Section  
3.1. Ethics Statement  
Ethical approval was obtained from the Leicestershire and Rutland local research ethics committee 
and all research procedures were conducted according to the principles expressed in the Declaration  
of Helsinki.  
3.2. Subjects  
Volunteers were recruited from the Women’s Hospital, University Hospitals of Leicester NHS 
Trust and were either attending as emergencies with a diagnosis of ectopic pregnancy or were  
non-pregnant volunteers having total abdominal hysterectomy and bilateral salpingoophorectomy 
(TAH & BSO) for benign gynaecological conditions such as fibroids or dysfunctional uterine bleeding. 
The non-pregnant were categorised into two groups based on their last menstrual period (LMP) and 
endometrial histology according to Noyes criteria i.e., follicular phase (days 4–9) and luteal phase 
(days 20–25). Exclusion criteria included women with a levonorgestrel intrauterine system (Mirena®), 
on prescription or recreational drugs, or with chronic medical conditions or previous pelvic inflammatory 
disease (PID). Fallopian tubes and endometrial biopsies were obtained from a total of 12 volunteers 
[ectopic pregnancy (n = 4), follicular (n = 4) and luteal (n = 4)] after written and informed consent. 
The choice of non-pregnant women (particularly the luteal phase) as a comparison group is consistent 
with current practice as it is unethical and difficult to obtain fallopian tubes from women in the first 
trimester of pregnancy. 
3.3. Tissue Collection  
Tissue biopsies were collected immediately following TAH & BSO or following salpingectomy for 
ectopic pregnancy, washed (to remove blood) with sterile 1X phosphate buffered saline (PBS) and 
placed into sterile polypropylene tubes. Samples were immediately transported to the laboratory in 
liquid nitrogen and stored at −80 °C for later RNA extraction.  
3.4. Isolation of RNA and cDNA Synthesis  
Tissues obtained (50 mg) were homogenised in a mortar and total RNA extracted using Qiagen 
miRNeasy mini kit (50) (Qiagen, Crawley, UK) according to the manufacturer’s instructions. The 
RNA obtained was treated with DNAse to eliminate contaminating DNA prior to storage at −20 °C for 
future use. The yield and purity of isolated RNA was determined using a Nanodrop ND-1000 UV 
spectrophotometer (Nanodrop technologies, Wilmington, DE, USA) and samples selected for  
RT-qPCR had A260/280 absorbance ratios greater than 1.9. RNA integrity was assessed using an Agilent 
bioanalyser 2100 (Agilent Technologies, Wokingham, UK) and samples with RNA integrity number 
(RIN) of greater than seven were considered suitable for RT-qPCR. 
First strand cDNA was synthesised from 1 µg of DNA free RNA using a high capacity  
RNA-to-cDNA reverse transcription kit (Applied biosystems, Warrington, UK) according to the 
manufacturer’s instructions. The final 20 µL reaction volume contained 10 µL of 2× RT buffer, 1 µL 
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of 20× RT enzyme and 1 µg of total RNA diluted with molecular grade water to a final volume of  
9 µL. A No RT reaction (RT-minus) was included to confirm the absence of contaminating DNA. The 
thermal conditions for reverse transcription were 37 °C for 1 h followed by 95 °C for 5 min before 
storage at −20 °C for future use.  
3.5. Quantitative Real-Time PCR  
Experiments were performed using the human geNormTM reference gene selection kit containing 
validated lyophilised primer sets for 12 reference genes (PrimerDesign, Southampton, UK). All 
reactions were carried out in a final reaction volume of 20 μL containing 10 μL of 2× SYBR Green 
PCR Universal Master Mix (Applied Biosystems, Warrington, UK), 300 nM primer mix of reference 
genes or 900 nM of NAPE-PLD primers (genbank accession number NM_198990), 1 μL of cDNA and 
8 μL of molecular grade water. Amplifications were performed starting with 95 °C for 10 min for 
enzyme activation, followed by 40 cycles of template denaturation step at 95 °C for 15 s, data 
collection for 60 s at 60 °C followed by extension at 72 °C. RT-minus and no template controls (NTC) 
containing molecular grade water instead of template mRNA were included with each run. No product 
was synthesised in the NTC and RT-minus confirming the absence of contaminating DNA. All 
reactions for the reference genes were performed in triplicate according to the manufacturer’s protocol 
using ABI PRISM® 7000 system (Applied Biosystems, Warrington, UK). Analysis of dissociation 
curves for all primers showed a single peak. To calculate the PCR efficiency of primers for  
NAPE-PLD as the test gene of interest, standard curves were constructed which showed a linear 
relationship between template quantity and target gene expression. The gradient of the standard curve 
for the target gene was used to calculate the PCR efficiency according to the formula: Efficiency 
(E)(%) = (A − 1) × 100 where A = 10[−1/slope of standard curve]. The PCR efficiency for NAPE-PLD was 
93.1% with a linear correlation coefficient (R2) of 0.972. 
3.6. Software Determination of Reference Genes Stability  
For stability comparisons of reference genes, two algorithms were used i.e., geNorm version 3.5 [18] 
and NormFinder version 0.953 [19] according to their original publications. Data on accumulated 
standard deviation was obtained from the NormFinder algorithm incorporated into the GenEx software 
version 5.3.6.170 [20]. Details of the statistical methods used by both geNorm and NormFinder have 
been described elsewhere [21–23]. 
3.7. Gene Expression Stability Analysis  
The mRNA expression level for each of the 12 endogenous reference genes was obtained using the 
mean RT-qPCR threshold cycle (Ct) value. This is defined as the number of cycles needed for the 
fluorescence to reach a specific threshold level of detection and is inversely correlated with the amount 
of template nucleic acid present in the reaction. Cq values obtained from the ABI PRISM® 7000 
(Applied Biosystems, Warrington, UK) output data file were converted to relative expression values 
using the 2−∆∆Cq method [16]. Briefly,  
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i. The highest Cq value was subtracted from all other Cq values for each gene measured. This 
gave a delta Cq value (ΔCq) with the highest delta Cq value being 0. All other values were less 
than 0. 
ii. To each ΔCq value, the equation (2−ΔCq) was applied. Hence all data were expressed relative to 
the expression of the least expressed gene. Relative expression values were exported to 
geNorm and NormFinder for analysis.  
3.8. Statistical Analysis  
Except otherwise stated, data for the genes of interest were expressed as mean ± standard error of 
the mean (SEM) or standard deviation (SD) and p values obtained using one-way analysis of variance 
(ANOVA) followed by appropriate post hoc analysis using GraphPad Prism version 5.00 for  
Windows [24]. A p value of less than 0.05 was accepted as significant. 
4. Conclusions  
Altogether, our results suggest that certain genes may be more suitable as reference genes in 
fallopian tubes or endometrium than others. The current widespread use of RN18S1, GAPDH and  
β-actin in the absence of appropriate validation should be avoided. Despite the limited sample size, at 
the very least, it does emphasise the importance of a systematic process being needed to choose an 
appropriate reference gene, and that the arbitrary selection of internal controls genes may lead to 
misinterpretation of data.  
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